DHI vs RIGL · P/E 9.6, rev $34.25B vs P/E 9.1, rev $137.5M
DR Horton Inc (DHI) versus Rigel Pharmaceuticals Inc (RIGL) — a side-by-side from cached financials, not a winner call.
DR Horton Inc (DHI) is a residential construction company listed on US.
Rigel Pharmaceuticals Inc (RIGL) is a biotechnology company listed on US.
Latest reported DHI revenue for 2025-09-30 was $34.25B. Net income was $3.62B. DHI currently screens at market cap $39.10B and trailing P/E 9.6.
Latest reported RIGL revenue for 2026-06-30 was $137.5M. Net income was $25.9M. RIGL currently screens at market cap $338.3M and trailing P/E 9.1.
DHI currently screens at market cap $39.10B and trailing P/E 9.6. RIGL currently screens at market cap $338.3M and trailing P/E 9.1.
Not investment advice. Open the DHI and RIGL stock pages for the full models.
Not investment advice.